DK0785274T3 - Kunstigt rekombinant substrat (rAGG-1) og nativ aggrecan til undersøgelse af den proteolytiske aktivitet af "aggrecanase" i - Google Patents

Kunstigt rekombinant substrat (rAGG-1) og nativ aggrecan til undersøgelse af den proteolytiske aktivitet af "aggrecanase" i

Info

Publication number
DK0785274T3
DK0785274T3 DK96120949T DK96120949T DK0785274T3 DK 0785274 T3 DK0785274 T3 DK 0785274T3 DK 96120949 T DK96120949 T DK 96120949T DK 96120949 T DK96120949 T DK 96120949T DK 0785274 T3 DK0785274 T3 DK 0785274T3
Authority
DK
Denmark
Prior art keywords
aggrecanase
recombinant substrate
study
human igg1
region
Prior art date
Application number
DK96120949T
Other languages
English (en)
Inventor
Eckart Bartnik
Bernd Eidenmueller
Frank Buettner
Bruce Caterson
Clare Hughes
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK0785274T3 publication Critical patent/DK0785274T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/02Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4725Proteoglycans, e.g. aggreccan
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1037Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DK96120949T 1996-01-18 1996-12-27 Kunstigt rekombinant substrat (rAGG-1) og nativ aggrecan til undersøgelse af den proteolytiske aktivitet af "aggrecanase" i DK0785274T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96100682 1996-01-18

Publications (1)

Publication Number Publication Date
DK0785274T3 true DK0785274T3 (da) 2000-12-27

Family

ID=8222415

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96120949T DK0785274T3 (da) 1996-01-18 1996-12-27 Kunstigt rekombinant substrat (rAGG-1) og nativ aggrecan til undersøgelse af den proteolytiske aktivitet af "aggrecanase" i

Country Status (11)

Country Link
US (2) US5872209A (da)
EP (1) EP0785274B1 (da)
JP (1) JP3973253B2 (da)
AT (1) ATE196652T1 (da)
AU (1) AU713828B2 (da)
CA (1) CA2195385C (da)
DE (1) DE69610483T2 (da)
DK (1) DK0785274T3 (da)
ES (1) ES2150064T3 (da)
GR (1) GR3034649T3 (da)
PT (1) PT785274E (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0785274B1 (en) * 1996-01-18 2000-09-27 Aventis Pharma Deutschland GmbH An artifical recombinant substrate (rAGG-1) and native aggrecan to study the proteolytic activity of 'Aggrecanase' in cell culture systems
WO1999005291A2 (en) 1997-07-25 1999-02-04 Du Pont Pharmaceuticals Company Aggrecan degrading metallo proteases
AU8513098A (en) * 1998-07-24 2000-02-14 Du Pont Pharmaceuticals Company Assays and peptide substrate for determining aggrecan degrading metallo proteaseactivity
US6649377B1 (en) 1999-05-10 2003-11-18 Syntex (U.S.A.) Llc Human aggrecanase and nucleic acid compositions encoding the same
AU2002335747B2 (en) 2001-09-15 2009-01-29 Rush University Medical Center Stratified cartilage tissue and methods to engineer same
US20030165473A1 (en) * 2001-11-09 2003-09-04 Rush-Presbyterian-St. Luke's Medical Center Engineered intervertebral disc tissue
DE102004029470A1 (de) * 2004-06-18 2006-01-05 InViTek Gesellschaft für Biotechnik & Biodesign mbH Verfahren zur Bestimmung von Aggrekanase-Aktivitäten
DE102005005972A1 (de) 2005-02-09 2006-08-17 Sanofi-Aventis Deutschland Gmbh Verwendung von Thiopeptoliden zur Aktivitätsbestimmung von ADAM-T8 Proteasen
EP2315842A2 (en) * 2008-07-28 2011-05-04 Dorit Arad Methods and compositions for detection of a pathogen, disease, medical condition, or biomarker thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5427954A (en) * 1992-04-29 1995-06-27 Shriner's Hospitals For Crippled Children Compositions and methods for detection and treatment of human osteoarthritis
GB9310978D0 (en) * 1993-05-27 1993-07-14 Zeneca Ltd Compounds
US5851523A (en) * 1994-03-24 1998-12-22 Ludwig Institute For Cancer Research. Isolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereof
SE9500023L (sv) * 1994-05-17 1995-11-18 Beki Ab Sätt att detektera cancer
EP0785274B1 (en) * 1996-01-18 2000-09-27 Aventis Pharma Deutschland GmbH An artifical recombinant substrate (rAGG-1) and native aggrecan to study the proteolytic activity of 'Aggrecanase' in cell culture systems

Also Published As

Publication number Publication date
DE69610483T2 (de) 2001-06-13
ES2150064T3 (es) 2000-11-16
US5872209A (en) 1999-02-16
JP3973253B2 (ja) 2007-09-12
PT785274E (pt) 2001-01-31
US6180334B1 (en) 2001-01-30
DE69610483D1 (de) 2000-11-02
AU1019997A (en) 1997-07-24
EP0785274A1 (en) 1997-07-23
CA2195385C (en) 2010-07-27
EP0785274B1 (en) 2000-09-27
GR3034649T3 (en) 2001-01-31
ATE196652T1 (de) 2000-10-15
AU713828B2 (en) 1999-12-09
CA2195385A1 (en) 1997-07-19
JPH09191889A (ja) 1997-07-29

Similar Documents

Publication Publication Date Title
BG102265A (bg) Метод и състав за лечение на имунологични заболявания
DK0914155T3 (da) Monoklonale antistoffer, der er spepcifikke for det ekstracellulære domæne af prostataspecifikt membran-antigen
DK0692025T3 (da) Gærceller, der er konstrueret således, at de producerer surrogater for proteiner i feromonsystemet, og anvendelser deraf
LU90592I2 (fr) Enbrel-etanercept
ATE350475T1 (de) Rezeptor an der oberfläche von aktivierten t- zellen:act4
DK0943097T3 (da) Fremgangsmåde til at påvise IgE
DK0741784T3 (da) Ligand (ACT-4-L) til en receptor på overfladen af aktiverede CD4+ T-celler
BR9712955A (pt) Peptìdio derivado de um antìgeno reconhecido por auto-anticorpos de pacientes com artrite reumatóide, anticorpo direcionado contra o dito peptìdeo, antìgeno combinatório e método de detecção de anticorpos auto-imunes
ATE502578T1 (de) Messung der protein-syntheseraten bei menschen und in experimentellen systemen durch verwendung von isotopisch markiertem wasser
BR9916325A (pt) Método para expressão de alto nìvel de proteìnas quiméricas de imunoglobulina de receptor de linfotoxina-beta ativas e sua purificação
DK0785274T3 (da) Kunstigt rekombinant substrat (rAGG-1) og nativ aggrecan til undersøgelse af den proteolytiske aktivitet af "aggrecanase" i
DK0528932T3 (da) Protein associeret med akut pancreatitis og midler til diagnose af akut pancreatitis
SE9500023L (sv) Sätt att detektera cancer
DK0741870T3 (da) Fremgangsmåde til kvantificering af LBP i kropsvæsker
DE69821246D1 (de) Testverfahren für collagenpeptid
ATE466020T1 (de) Neue isoform des gefässendothelzell wachstumshemmers (vegi)
DK0960336T3 (da) Peptidreagens til påvisning af humant cytomelagovirus (CMV)
ATE389881T1 (de) Detektion von kleinen molekülen mit piezo- elektrischem sensor
SE0000675D0 (sv) Monoclonal antibodies
ATE513040T1 (de) Zinkfingerdomänenbibliotheken
DE60034966D1 (de) Auswertung von biologischen mitteln in lebenden zielzellen
DK0815451T3 (da) Fremgangsmåde til undersøgelse af husstøv og anvendelse af et detekteringsmiddel
ATE265533T1 (de) Saeugetierchemokine
DE59710668D1 (de) Monoklonale antikörper gegen das epitop ypydvpdya, verfahren zu deren herstellung und ihre verwendung
ES2119992T3 (es) Anticuerpos especificos de 6-o-metilguanina-adn-metiltransferasa (mgmt).